Peter Joe Pitts
CIK: 0002138486
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BCLI
BRAINSTORM CELL THERAPEUTICS INC.
DirectorOfficer
Discretionary Trading P&L
Holdings
About Pitts Peter Joe
Pitts Peter Joe (SEC CIK 0002138486) files insider reports with the SEC as Executive Chairman of BRAINSTORM CELL THERAPEUTICS INC. (BCLI).
Signal8 holds 2 ownership filings by Pitts Peter Joe (1 Form 3, 1 Form 4), filed between Jun 3, 2026 and Jul 28, 2026. Those filings report 1 transaction, the latest on Jul 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Pitts Peter Joe's filings is in NEW YORK, NY.
Recent filings by Pitts Peter Joe
- Jul 24, 2026: Grant or award of BCLI derivative securities (Form 4, code A).
Other insiders filing for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
- FRENKEL JACOB A, Director
- Lebovits Chaim, President & CEO
- Yablonka Uri, EVP & Chief Business Officer
- Patlis Alla
- ARBEL IRIT, Director
- Bairu Menghisteab, Director